Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Pommier

Showing results (21-30 of 625) with videos related to

Pageof 63
Sort By:
NAR Cancer|August 21, 2023
R-loops, type I topoisomerases and cancerSourav Saha, Yves Pommier
Nature Protocols|October 18, 2008
DNA cleavage assay for the identification of topoisomerase I inhibitorsThomas S Dexheimer, Yves Pommier
Cancer Research|December 23, 2011
Potentiation of the novel topoisomerase I inhibitor indenoisoquinoline LMP-400 by the cell checkpoint and Chk1-Chk2 inhibitor AZD7762Sheena M Aris, Yves Pommier
Nucleic Acids Research|September 12, 2013
Sequence selectivity of the cleavage sites induced by topoisomerase I inhibitors: a molecular dynamics studyFung-Ming Siu, Yves Pommier
Medecine Sciences : M/S|July 3, 2003
[Cell cycle and checkpoints in oncology: new therapeutic targets]Yves Pommier, Kurt W Kohn
The Biochemical Journal|January 25, 2008
Role of a tryptophan anchor in human topoisomerase I structure, function and inhibitionGary S Laco, Yves Pommier
Biochemical and Biophysical Research Communications|May 4, 2005
Molecular interaction map of the p53 and Mdm2 logic elements, which control the Off-On switch of p53 in response to DNA damageKurt W Kohn, Yves Pommier
Nature Biotechnology|November 10, 2006
Connecting genes, drugs and diseasesJohn N Weinstein, Yves Pommier
Comptes Rendus Biologies|January 28, 2004
Transcriptomic analysis of the NCI-60 cancer cell linesJohn N Weinstein, Yves Pommier
Cell Cycle (Georgetown, Tex.)|February 11, 2024
TOP3A coupling with replication forks and repair of TOP3A cleavage complexesLiton Kumar Saha, Yves Pommier
Pageof 63

Showing results (21-30 of 625) with videos related to

Sort By:
Pageof 63
NAR Cancer|August 21, 2023
R-loops, type I topoisomerases and cancerSourav Saha, Yves Pommier
Nature Protocols|October 18, 2008
DNA cleavage assay for the identification of topoisomerase I inhibitorsThomas S Dexheimer, Yves Pommier
Cancer Research|December 23, 2011
Potentiation of the novel topoisomerase I inhibitor indenoisoquinoline LMP-400 by the cell checkpoint and Chk1-Chk2 inhibitor AZD7762Sheena M Aris, Yves Pommier
Nucleic Acids Research|September 12, 2013
Sequence selectivity of the cleavage sites induced by topoisomerase I inhibitors: a molecular dynamics studyFung-Ming Siu, Yves Pommier
Medecine Sciences : M/S|July 3, 2003
[Cell cycle and checkpoints in oncology: new therapeutic targets]Yves Pommier, Kurt W Kohn
The Biochemical Journal|January 25, 2008
Role of a tryptophan anchor in human topoisomerase I structure, function and inhibitionGary S Laco, Yves Pommier
Biochemical and Biophysical Research Communications|May 4, 2005
Molecular interaction map of the p53 and Mdm2 logic elements, which control the Off-On switch of p53 in response to DNA damageKurt W Kohn, Yves Pommier
Nature Biotechnology|November 10, 2006
Connecting genes, drugs and diseasesJohn N Weinstein, Yves Pommier
Comptes Rendus Biologies|January 28, 2004
Transcriptomic analysis of the NCI-60 cancer cell linesJohn N Weinstein, Yves Pommier
Cell Cycle (Georgetown, Tex.)|February 11, 2024
TOP3A coupling with replication forks and repair of TOP3A cleavage complexesLiton Kumar Saha, Yves Pommier
Pageof 63